ClinicalTrials.Veeva

Menu

Vaginal Cleaning Using Povidone Iodine Before CS to Reduce Postoperative Wound Infection

Cairo University (CU) logo

Cairo University (CU)

Status and phase

Enrolling
Phase 3

Conditions

Cesarean Section Complications
Vaginal Infection
Postoperative Infection

Treatments

Drug: 10% povidone iodine

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of work to assess the effectiveness of preoperative vaginal cleansing with povidone iodine on reduction of post caesarean section wound infection

Research questions:

Does vaginal cleaning using povidone iodine before cesarean section has effect on reduction of postoperative wound infection??

Enrollment

800 estimated patients

Sex

Female

Ages

18 to 38 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    1. Pregnant women who are 37 weeks gestation or more scheduled for elective cesarean section or those in labor with a limited number of vaginal examinations less than 5 times preoperatively.

    2. Pregnant women who are 37 weeks gestation or more with rupture of membranes but duration less than 24 hours

    3. Women consenting to be included in the study.

Exclusion criteria

  1. Abnormally invasive placenta and placenta previa.
  2. Intra-partum fever.
  3. Prolonged rupture of membranes more than 24 hours
  4. History of exposure to radiation treatment for cancer.
  5. History of Gynecological infections (PID).
  6. History of abdominal infections, e.g., peritonitis.
  7. Debilitating diseases like Diabetes mellitus, Thyroid disorders, Cushing disease, abdominal malignancy.
  8. Obesity is defined as pregnant BMI >30 kg/m2.
  9. History of wound infection or burst abdomen.
  10. History suggestive of massive bleeding during previous cesarean section.
  11. allergy to iodine-containing solutions
  12. Pregnant women with severe anemia defined as Hb <7 g/dl.
  13. Cases with intra-abdominal drain deployment are discarded.
  14. Obstructed labor with numerous vaginal examinations.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

800 participants in 2 patient groups

Iodine group
Experimental group
Description:
50 women who received preoperative vaginal cleansing with 10% povidone-iodine.
Treatment:
Drug: 10% povidone iodine
Control group
No Intervention group
Description:
50 women who did not receive preoperative vaginal cleansing even with tap water.

Trial contacts and locations

2

Loading...

Central trial contact

Waleed M El-Khayat, MD; Mohammed A Taymour, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems